Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation
Open Access
- 15 November 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in Human Reproduction Update
- Vol. 14 (1), 1-14
- https://doi.org/10.1093/humupd/dmm034
Abstract
Ovarian stimulation is applied in the clinic to restore mono-ovulatory cycles in anovulatory women (ovulation induction) or to induce the development of multiple dominant follicles for assisted reproduction. Ovarian response is the endocrine and follicular reaction of the ovaries to stimulation. Achieving an appropriate ovarian response to anti-estrogens or exogenous gonadotrophins is central to ovulation induction and ovarian stimulation protocols. However, achieving an adequate response, without cycle cancellation or adverse events related to under- or over-stimulation, is complicated by high intra- and inter-individual variability. To predict each patient's ovarian response to medication for ovarian stimulation and to individualize the starting dose of exogenous gonadotrophin or the need for exogenous luteinizing hormone, various clinical, endocrine, ovarian ultrasonographic and genetic characteristics have been explored. Some of these features have been incorporated into prediction models. In this review, the methodology behind predictive factors and prediction models and their potential clinical applicability across ovulation induction and ovarian stimulation are explored.Keywords
This publication has 108 references indexed in Scilit:
- Evaluation of an existing nomogram for predicting the response to clomiphene citrateFertility and Sterility, 2007
- Female reproductive ageing: current knowledge and future trendsTrends in Endocrinology & Metabolism, 2007
- Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndromeFertility and Sterility, 2006
- Patient-tailored conventional ovulation induction algorithms in anovulatory infertilityTrends in Endocrinology & Metabolism, 2005
- Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulationPharmacogenetics and Genomics, 2005
- Intercycle variabilities of basal antral follicle count and ovarian volume in subfertile women and their relationship to reproductive aging: A prospective studyGynecological Endocrinology, 2005
- Impact of recombinant FSH dose adjustments on ovarian response in the second treatment cycle with IVF or ICSI in “standard” patients treated with 150 IU/day during the first cycleActa Obstetricia et Gynecologica Scandinavica, 2004
- A poor response in the first in vitro fertilization cycle is not necessarily related to a poor prognosis in subsequent cyclesFertility and Sterility, 2004
- A prospective randomized clinical trial of differing starter doses of recombinant follicle-stimulating hormone (follitropin-β) for first time in vitro fertilization and intracytoplasmic sperm injection treatment cyclesFertility and Sterility, 2001
- Statistics and ethics in medical research. VII--Interpreting results.BMJ, 1980